REQUEST A DEMO
Total
USD $0.00
Search more companies

Endemed Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Endemed Sp. z o.o. Profile Updated: February 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Endemed Sp. z o.o. is based in Poland, with the head office in Siedlce. The company operates in the Pharmacies and Drug Stores sector. It was first established on February 18, 2002. There are currently 21 - 50 (2012) people employed by Endemed Sp. z o.o.. The latest financial highlights indicate a net sales revenue drop of 47.48% in 2023. Its’ total assets recorded a negative growth of 32.04%. The net profit margin of Endemed Sp. z o.o. increased by 5.15% in 2023.

Headquarters
Ul. 3-Go Maja 52/4
Siedlce; Mazowieckie; Postal Code: 08-110

Contact Details: Purchase the Endemed Sp. z o.o. report to view the information.

Website: http://www.endemed.pl

Basic Information
Total Employees:
Purchase the Endemed Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Endemed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Endemed Sp. z o.o. report to view the information.
Incorporation Date:
February 18, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Endemed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-47.48%
Total operating revenue
-47.48%
Operating profit (EBIT)
66.7%
EBITDA
72.26%
Net Profit (Loss) for the Period
66.7%
Total assets
-32.04%
Total equity
-3.49%
Operating Profit Margin (ROS)
5.15%
Net Profit Margin
5.15%
Return on Equity (ROE)
6.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?